Skip to main content

Newsroom press releases

21/12/18 - 11:30

DiaSorin launches 3 new primer pairs for use in molecular testing (438.25 KB)
Products Molecular

04/12/18 - 8:00

DiaSorin's stocks listed in the FTSE MIB (464.63 KB)
Financial Data

19/11/18 - 15:00

DiaSorin launches Simplexa Group B Strep Direct molecular assay in the United States (435.43 KB)
Products Molecular

07/11/18 - 13:00

DiaSorin Group reports growth in revenues and net profit in the first nine months of 2018 (961.72 KB)
Financial Data

17/10/18 - 11:51

DiaSorin launches Simplexa Group B Strep Direct molecular assay in the european market (147.78 KB)
Products Molecular

12/10/18 - 11:47

DiaSorin launches Simplexa VZV Direct molecular assay in the european market (444.81 KB)
Products Molecular

09/10/18 - 11:35

DiaSorin and Meridian enter into a strategic collaboration to sell Helicobacter pylori stool antigen test in the United States and in the United Kingdom (471.21 KB)
Acquisition / Partnership

17/09/18 - 11:28

DiaSorin launches the new LIASON quantiFERON-TB Gold Plus assay as an aid for latent tuberculosis detection in partnership with Qiagen (753.85 KB)
Products Immunodiagnostic

07/08/18 - 8:45

Communication on total amount of voting rights (305.24 KB)
Financial Data

02/08/18 - 12:45

The Board of Directors approves the results for the first half of 2018 (883.1 KB)
Financial Data

27/07/18 - 12:00

DiaSorin launches Hepatitis Delta (HDV) test on LIAISON XL platform (735.03 KB)
Products Immunodiagnostic

03/07/18 - 18:30

Conclusion treasury shares buy-back plan (397.33 KB)
Financial Data

03/07/18 - 18:30

Annex 3F (treasury shares buy back July 2018) (6.59 KB)
Financial Data

03/07/18 - 18:30

Report treasury shares buy-back (287.99 KB)
Financial Data

03/07/18 - 18:30

Annex 3F (treasury shares buy back June 2018) (8.69 KB)
Financial Data

29/06/18 - 18:15

Weekly report treasury shares buy-back (290.62 KB)
Financial Data

22/06/18 - 20:30

Weekly report treasury shares buy-back (290.6 KB)
Financial Data

15/06/18 - 21:00

Weekly report treasury shares buy-back (290.62 KB)
Financial Data

12/06/18 - 14:15

DiaSorin introduces primer pair reagents for use in molecular testing: Anaplasma phagocytophilum, Ehrlichia e Babesia (445.17 KB)
Products Molecular

08/06/18 - 23:15

Weekly report treasury shares buy-back (290.24 KB)
Financial Data

04/06/18 - 13:15

Annex 3F (treasury shares buy back May 2018) (8.54 KB)
Financial Data

01/06/18 - 20:15

Weekly report treasury shares buy-back (290.38 KB)
Financial Data

25/05/18 - 22:30

Weekly report treasury shares buy-back (289.97 KB)
Financial Data

19/05/18 - 1:45

Weekly report treasury shares buy-back (289.76 KB)
Financial Data

11/05/18 - 20:15

Weekly report treasury shares buy-back (290.77 KB)
Financial Data

08/05/18 - 14:30

The DiaSorin Group reports growth in revenues and profitability in the first quarter 2018 (832.84 KB)
Financial Data

03/05/18 - 20:15

Start up treasury shares buy-back plan (354.27 KB)
Financial Data

24/04/18 - 14:00

Annex 3F (treasury shares buy back) (7.77 KB)
Financial Data

23/04/18 - 18:30

Annual General Meeting 2018 (589.65 KB)
Financial Data

19/04/18 - 21:15

Conclusion treasury shares buy-back plan (397.59 KB)
Financial Data

19/04/18 - 21:00

Weekly report treasury shares buy-back (289.29 KB)
Financial Data

13/04/18 - 20:30

Weekly report treasury shares buy-back (290.07 KB)
Financial Data

06/04/18 - 19:45

Weekly report treasury shares buy-back (288.33 KB)
Financial Data

05/04/18 - 12:00

DiaSorin receives FDA clearance for the LIAISON BRAHMS PCT II GEN assay to detect severe bacterial infections (e.g. Sepsis) (737.88 KB)
Products Immunodiagnostic

04/04/18 - 20:00

Start up treasury shares buy-back plan (346.04 KB)
Financial Data

28/03/18 - 18:45

DiaSorin earns FDA clearence extending sample claims for Simplexa HSV 1 & 2 direct molecular test (442.69 KB)
Products Molecular

07/03/18 - 15:30

DiaSorin: FY 2017 Results (1.14 MB)
Financial Data

30/01/18 - 11:45

DiaSorin signs an agreement with the Italian Tax Authority granting tax relief under the Italian Patent Box regime (574.68 KB)
Financial Data

08/01/18 - 9:00

QIAGEN and DiaSorin partner to offer fully automated tuberculosis detection with QuantiFERON-TB Gold Plus available on LIAISON analyzer systems (483.2 KB)
Acquisition / Partnership

08/01/18 - 9:00

QIAGEN and DiaSorin partner to offer fully automated tuberculosis detection with QuantiFERON-TB Gold Plus available on LIAISON analyzer systems (483.2 KB)
Acquisition / Partnership

23/12/11 - 1:00

Financial instruments to employees (57.22 KB)
Financial Data

19/12/11 - 1:00

Clostridium Difficile toxins A and B in stool on LIAISON (available outside the US and Canada only) (192.66 KB)
Products Immunodiagnostic

19/11/11 - 1:00

Buy-back plan (35.47 KB)
Financial Data

18/11/11 - 1:00

Financial instruments to employees (56.82 KB)
Financial Data

11/11/11 - 1:00

The BoD approves Q3'11 results (334.35 KB)
Financial Data

28/10/11 - 2:00

Buy-back plan (103.99 KB)
Financial Data

25/10/11 - 2:00

Buy-back plan (104.72 KB)
Financial Data

18/10/11 - 2:00

Buy-back plan (136.18 KB)
Financial Data

17/10/11 - 2:00

2011-2015 Business Plan: a new business wave (195.1 KB)
Financial Data

10/10/11 - 2:00

New Chief Financial Officer (196.26 KB)
Other

06/10/11 - 2:00

Cardinal Health: agreement extended to 2014 (192.57 KB)
Acquisition / Partnership

04/10/11 - 2:00

Buy-back plan (204.92 KB)
Financial Data

01/09/11 - 2:00

Resignation of Chief Financial Officer (177.77 KB)
Other

31/08/11 - 2:00

2011 Financial calendar update (176.4 KB)
Financial Data

03/08/11 - 2:00

The BoD approves H1'11 results (324.48 KB)
Financial Data

11/07/11 - 2:00

Voluntarily removal from the STAR segment (194.93 KB)
Financial Data

13/05/11 - 2:00

The BoD approves Q1'11 results (307.28 KB)
Financial Data

11/05/11 - 2:00

DiaSorin and Labcorp extend strategic business relationship (100.01 KB)
Acquisition / Partnership

06/05/11 - 2:00

Agreement with Precision System Science Co., LTD (171.54 KB)
Acquisition / Partnership

28/04/11 - 2:00

The Ordinary Shareholders' meeting approves the 2010 statutory financial statements and the dividend distribution (175.61 KB)
Financial Data

16/03/11 - 1:00

The BoD approves FY'10 results (368.28 KB)
Financial Data

16/03/11 - 1:00

Dividend information amendment (159.83 KB)
Financial Data

28/02/11 - 1:00

2011 Financial calendar update (179.92 KB)
Financial Data

19/02/11 - 1:00

Notice of change in share capital (5.28 KB)
Financial Data

18/02/11 - 1:00

Buy-back plan (134.06 KB)
Financial Data

17/02/11 - 1:00

Financial instruments to employees (56.37 KB)
Financial Data

16/02/11 - 1:00

Buy-back plan (105.2 KB)
Financial Data

15/02/11 - 1:00

Buy-back plan (91.38 KB)
Financial Data

14/02/11 - 1:00

The BoD approves Q4'10 results (161 KB)
Financial Data

31/01/11 - 1:00

Buy-back plan (105.05 KB)
Financial Data

29/01/11 - 1:00

Buy-back plan (105.2 KB)
Financial Data

28/01/11 - 1:00

Buy-back plan (105.04 KB)
Financial Data

27/01/11 - 1:00

Buy-back plan (105.04 KB)
Financial Data

26/01/11 - 1:00

FDA approves the LIAISON XL (194.2 KB)
Products Immunodiagnostic

25/01/11 - 1:00

Buy-back plan (105.22 KB)
Financial Data

24/01/11 - 1:00

Buy-back plan (104.72 KB)
Financial Data

21/01/11 - 1:00

Buy-back plan (105.05 KB)
Financial Data

20/01/11 - 1:00

Buy-back plan (91.39 KB)
Financial Data

19/01/11 - 1:00

Buy-back plan (105.31 KB)
Financial Data

18/01/11 - 1:00

Buy-back plan (35.47 KB)
Financial Data

17/01/11 - 1:00

Buy-back plan (134.01 KB)
Financial Data

17/01/11 - 1:00

The Sonic Healthcare Group chooses DiaSorin (181.71 KB)
Acquisition / Partnership

16/01/11 - 1:00

2011 Financial calendar (179.49 KB)
Financial Data